About us

about us

Encare Team

Mark de Boer

PhD Acting Chief Executive Officer

Mark has for the last twenty years worked for, managed and started early stage biopharmaceutical companies in the field of innovative novel biopharmaceuticals. He currently is a Venture Partner at Index Ventures for one day per week and in that capacity has been chairman of ProFibrix in Leiden and served on the board of several other Index portfolio companies including Molecular Partners in Switserland and Versartis in California. He has founded several biotech companies in The Netherlands including PanGenetics/FFPharma were he serves as CEO on a part time basis.